1. Home
  2. CGEN vs INBK Comparison

CGEN vs INBK Comparison

Compare CGEN & INBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • INBK
  • Stock Information
  • Founded
  • CGEN 1993
  • INBK 1999
  • Country
  • CGEN Israel
  • INBK United States
  • Employees
  • CGEN N/A
  • INBK N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • INBK Major Banks
  • Sector
  • CGEN Health Care
  • INBK Finance
  • Exchange
  • CGEN Nasdaq
  • INBK Nasdaq
  • Market Cap
  • CGEN 167.4M
  • INBK 191.0M
  • IPO Year
  • CGEN 2000
  • INBK N/A
  • Fundamental
  • Price
  • CGEN $1.45
  • INBK $24.63
  • Analyst Decision
  • CGEN
  • INBK Hold
  • Analyst Count
  • CGEN 0
  • INBK 3
  • Target Price
  • CGEN N/A
  • INBK $30.67
  • AVG Volume (30 Days)
  • CGEN 206.7K
  • INBK 36.2K
  • Earning Date
  • CGEN 08-06-2025
  • INBK 10-22-2025
  • Dividend Yield
  • CGEN N/A
  • INBK 0.98%
  • EPS Growth
  • CGEN N/A
  • INBK N/A
  • EPS
  • CGEN N/A
  • INBK 1.76
  • Revenue
  • CGEN $22,144,000.00
  • INBK $106,219,000.00
  • Revenue This Year
  • CGEN N/A
  • INBK $6.07
  • Revenue Next Year
  • CGEN $159.40
  • INBK $26.33
  • P/E Ratio
  • CGEN N/A
  • INBK $13.89
  • Revenue Growth
  • CGEN N/A
  • INBK 4.74
  • 52 Week Low
  • CGEN $1.13
  • INBK $19.54
  • 52 Week High
  • CGEN $2.66
  • INBK $43.27
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 48.38
  • INBK 52.47
  • Support Level
  • CGEN $1.39
  • INBK $23.85
  • Resistance Level
  • CGEN $1.46
  • INBK $25.09
  • Average True Range (ATR)
  • CGEN 0.06
  • INBK 0.74
  • MACD
  • CGEN 0.00
  • INBK 0.09
  • Stochastic Oscillator
  • CGEN 52.63
  • INBK 55.99

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About INBK First Internet Bancorp

First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.

Share on Social Networks: